Health·2,850 stories
British Paralympian and NHS surgeon John McFall, who lost his right leg at 19, is set to train for a mission to Vast's Haven-1 commercial space station under a UK Space Agency deal, potentially becomi
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over ...
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, bu...
A daily oral KRAS inhibitor, daraxonrasib, has shown in a large trial to double median survival for metastatic pancreatic cancer patients who have exhausted chemotherapy, while causing far fewer side‑
Turmeric’s active compound curcumin has been marketed as a cure‑all, but its therapeutic promise is undercut by scientific and financial realities. Early work by Bharat Aggarwal sparked a $275 million
A 68‑year‑old Scottish lung‑cancer patient, Pat Brogan, saw his tumors shrink by nearly a third after receiving the experimental smart drug GRWD5769, which unmasks cancer cells to immunotherapy. The b
A phase‑1 trial of Oxford’s GRWD5769, taken with the immunotherapy cemiplimab, showed tumors shrink in 26 of 83 heavily pre‑treated cancer patients, with 15 achieving at least a 30% reduction across s
Salk Institute researchers discovered that supplementing mice with the dietary amino acid methionine dramatically improved survival during severe infections by enhancing kidney filtration and clearing
Revolution Medicines' second‑line pancreatic cancer drug daraxonrasib more than doubled median survival and cut death risk by 60% in a new study, prompting an FDA‑authorized early‑access rollout. At t
A one‑year course of the biologic drug abatacept can postpone the onset of rheumatoid arthritis by up to four years, even after treatment stops. The finding comes from a long‑term follow‑up of 213 hig
Families are demanding blood from unvaccinated donors, fearing vaccine residues, but hospitals say regulatory rules don’t label blood by donor vaccination status, leaving physicians caught between pat
French drugmaker Servier is acquiring Edgewise Therapeutics’ muscular dystrophy business for up to $2.65 billion, securing the oral candidate sevasemten, which is in pivotal trials for Becker and Phas
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells t...
A long-overlooked organ may hold surprising clues to healthy aging and cancer survival
Kenyan youths rallied in Nanyuki to block a U.S.-planned Ebola quarantine at Laikipia Air Base, a project the High Court has paused amid concerns over the country’s fragile health system and local exp
The arbitration process has protected patients but generated financial windfalls for some clinicians.
General Catalyst’s October acquisition of Summa Health is being used as a testbed for a rapid‑tech transformation led by Health Assurance Transformation Company. The plan rolls out AI‑driven phone cal
A new study of 120 bird species reveals that self‑pleasuring is a widespread, natural behavior in wild birds, challenging the view that it is a stress‑induced response to captivity and that interventi
A new daily pill, daraxonrasib, has been shown to nearly double survival for patients with advanced pancreatic cancer by targeting the KRAS mutation. In a 500‑patient trial across three continents, me
Australian biotech Cortical Labs has trained 200,000 lab-grown human brain cells on a silicon chip to play the 1990s shooter game Doom, demonstrating goal-directed learning in biological neurons and h
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.